(Reuters) - Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following are among the top-selling treatments for extremely rare disorders: Soliris, Alexion Pharmaceuticals - Treatment for a progressive disease that destroys red blood cells and a second condition that damages the kidney and other vital organs. Forecast 2012 sales: $1.1 billion. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment